Press Release 05.07.24
Office
Pillsbury opened its San Diego office to better serve the biotechnology and high-tech companies that have sprung up along the San Diego coast. Our office is often used by clients for board meetings, discussions with venture capital firms, and for senior management planning meetings. It’s not unusual for inventors or scientists to walk into our San Diego office and find an enthusiastic audience for their latest creation or discovery. Because many of our attorneys have advanced degrees in engineering and science, we provide particularly insightful representation. Equally important, we’ve integrated our wide-ranging corporate knowledge and experience with our strong experience in intellectual property issues for biotechnology and high-tech companies—ultimately offering complete, targeted legal solutions.
This office is committed to meeting every legal need of both emerging and established companies in the areas of:
Press Release 05.07.24
Press Release 05.07.24
Zokinvy is approved in the U.S. (2020), European Union and Great Britain (2022) and Japan (2024) for the treatment of progeria, a collection of ultra-rare, fatal, genetic premature aging diseases that accelerate mortality in young patients
Press Release 05.06.24
Awards & Rankings 04.09.24
Press Release 02.29.24
Press Release 02.27.24
Awards & Rankings 02.27.24
Awards & Rankings 02.16.24
Awards & Rankings 02.14.24
Media Coverage 01.25.24
Press Release 01.09.24
Awards & Rankings 01.08.24
Press Release 12.12.23
Press Release 12.06.23
Press Release 11.15.23
Press Release 11.14.23
Press Release 11.14.23
Press Release 11.06.23
Press Release 11.01.23
Awards & Rankings 10.26.23